Stay updated on Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.

Latest updates to the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA sitewide NIH banner announces updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check18 days agoChange DetectedThe revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now presents a 403 Forbidden error with a minimal layout, replacing detailed study content and metadata with a basic header/footer, while several non-essential sections and documents were removed.SummaryDifference19%

- Check66 days agoChange DetectedThe revision badge on the page updated from v3.6.5 to v3.6.6, representing a small maintenance release. There is no change to study details or clinical trial information.SummaryDifference0.0%

Stay in the know with updates to Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.